144 related articles for article (PubMed ID: 28224168)
1. Differential Clinicopathological Features in Spontaneous Regression of Melanomas and Melanocytic Naevi.
Martín JM; Pinazo I; Jordá E; Monteagudo C
Acta Derm Venereol; 2017 Jun; 97(6):692-697. PubMed ID: 28224168
[TBL] [Abstract][Full Text] [Related]
2. Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions.
Massi D; Franchi A; Sardi I; Magnelli L; Paglierani M; Borgognoni L; Maria Reali U; Santucci M
J Pathol; 2001 Jun; 194(2):194-200. PubMed ID: 11400148
[TBL] [Abstract][Full Text] [Related]
3. The dermoscopic classification of atypical melanocytic naevi (Clark naevi) is useful to discriminate benign from malignant melanocytic lesions.
Blum A; Soyer HP; Garbe C; Kerl H; Rassner G; Hofmann-Wellenhof R
Br J Dermatol; 2003 Dec; 149(6):1159-64. PubMed ID: 14674892
[TBL] [Abstract][Full Text] [Related]
4. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
Nasr MR; El-Zammar O
Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
[TBL] [Abstract][Full Text] [Related]
5. Distribution and colocalization of markers for proliferation, invasion, motility and neoangiogenesis in benign melanocytic naevi and malignant melanomas.
Fröhlich E; Mack AF; Garbe C; Klessen C
Br J Dermatol; 2005 Dec; 153(6):1159-65. PubMed ID: 16307652
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic and prognostic role of galectin 3 expression in cutaneous melanoma.
Abdou AG; Hammam MA; Farargy SE; Farag AG; El Shafey EN; Farouk S; Elnaidany NF
Am J Dermatopathol; 2010 Dec; 32(8):809-14. PubMed ID: 20885286
[TBL] [Abstract][Full Text] [Related]
7. Clinically equivocal melanocytic skin lesions with features of regression: a dermoscopic-pathological study.
Zalaudek I; Argenziano G; Ferrara G; Soyer HP; Corona R; Sera F; Cerroni L; Carbone A; Chiominto A; Cicale L; De Rosa G; Ferrari A; Hofmann-Wellenhof R; Malvehy J; Peris K; Pizzichetta MA; Puig S; Scalvenzi M; Staibano S; Ruocco V
Br J Dermatol; 2004 Jan; 150(1):64-71. PubMed ID: 14746618
[TBL] [Abstract][Full Text] [Related]
8. Proliferation indices correlate with diagnosis and metastasis in diagnostically challenging melanocytic tumors.
Al-Rohil RN; Curry JL; Torres-Cabala CA; Nagarajan P; Ivan D; Aung PP; Lyons GF; Bassett RL; Prieto VG; Tetzlaff MT
Hum Pathol; 2016 Jul; 53():73-81. PubMed ID: 27004944
[TBL] [Abstract][Full Text] [Related]
9. VS38 immunostaining in melanocytic lesions.
Shanks JH; Banerjee SS
J Clin Pathol; 1996 Mar; 49(3):205-7. PubMed ID: 8675729
[TBL] [Abstract][Full Text] [Related]
10. Angles and geometric shapes, but not lines, in melanocytic lesions may be helpful in the clinical diagnosis of melanoma.
Betti R; Cerri A; Vergani R; Agape E; Menni S
J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1432-4. PubMed ID: 25088534
[TBL] [Abstract][Full Text] [Related]
11. Pigmented spindle cell nevus: clues for differentiating it from spindle cell malignant melanoma. A comprehensive survey including clinicopathologic, immunohistochemical, and FISH studies.
Díaz A; Valera A; Carrera C; Hakim S; Aguilera P; García A; Palou J; Puig S; Malvehy J; Alos L
Am J Surg Pathol; 2011 Nov; 35(11):1733-42. PubMed ID: 21997694
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and distribution of melanocytic naevi on the scalp: a prospective study.
De Giorgi V; Sestini S; Grazzini M; Janowska A; Boddi V; Lotti T
Br J Dermatol; 2010 Feb; 162(2):345-9. PubMed ID: 19886886
[TBL] [Abstract][Full Text] [Related]
13. [Nevus associated malignant melanomas--diagnostic validation and prognosis].
Stadler R; Garbe C
Hautarzt; 1991 Jul; 42(7):424-9. PubMed ID: 1938395
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical investigation of alpha1 (IV) and alpha5 (IV) collagen chains in a broad spectrum of melanocytic tumours.
Quatresooz P; Piérard GE
Melanoma Res; 2005 Jun; 15(3):161-8. PubMed ID: 15917697
[TBL] [Abstract][Full Text] [Related]
15. A retrospective study addressed to understanding what predicts severe histological dysplasia/early melanoma in excised atypical melanocytic lesions.
Strauss RM; Elliott F; Affleck P; Boon AP; Newton-Bishop JA
Br J Dermatol; 2007 Oct; 157(4):758-64. PubMed ID: 17714559
[TBL] [Abstract][Full Text] [Related]
16. The "Umbrella Sign": A Useful Clue in the Diagnosis of Melanocytic Lesions in Sun Damaged Skin.
Wood BA; Harvey NT
Am J Dermatopathol; 2016 Jul; 38(7):504-9. PubMed ID: 26909586
[TBL] [Abstract][Full Text] [Related]
17. A zonal comparison of MIB1-Ki67 immunoreactivity in benign and malignant melanocytic lesions.
Li LX; Crotty KA; McCarthy SW; Palmer AA; Kril JJ
Am J Dermatopathol; 2000 Dec; 22(6):489-95. PubMed ID: 11190439
[TBL] [Abstract][Full Text] [Related]
18. Recurrent nevus phenomenon: a clinicopathologic study of 357 cases and histologic comparison with melanoma with regression.
King R; Hayzen BA; Page RN; Googe PB; Zeagler D; Mihm MC
Mod Pathol; 2009 May; 22(5):611-7. PubMed ID: 19270643
[TBL] [Abstract][Full Text] [Related]
19. Small-diameter melanocytic lesions: morphological analysis by means of in vivo confocal microscopy.
Pupelli G; Longo C; Veneziano L; Cesinaro AM; Ferrara G; Piana S; Moscarella E; Ricci C; Zalaudek I; Seidenari S; Argenziano G; Pellacani G
Br J Dermatol; 2013 May; 168(5):1027-33. PubMed ID: 23301553
[TBL] [Abstract][Full Text] [Related]
20. Melanocytic dysplastic naevi occupy the middle ground between benign melanocytic naevi and cutaneous malignant melanomas: emerging clues.
Hussein MR
J Clin Pathol; 2005 May; 58(5):453-6. PubMed ID: 15858113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]